CMND-100, a proprietary MEAI-based oral drug candidate, represents a potential breakthrough in AUD treatment, targeting the reduction of alcohol consumption and cravings through a novel mechanism of ...
Q4 2024 Earnings Call Transcript March 17, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the NRx ...
Myers Squibb Company, Johnson & Johnson, Bausch Health Companies Inc, AbbVie Inc. Read 's Market Analysis on Investing.com ...
An international team led by UPV/EHU and Biobizkaia reveals the relationship between placental DNA methylation and certain ...
VA4PA advocates take their case for PANS/PANDAS treatment coverage to the General Assembly in Richmond, VA Law to take effect July 1 <b ...
Severe self-injurious behavior in children with autism spectrum disorder (ASD) poses a significant risk of permanent physical injury.
Severe self-injurious behavior in children with autism spectrum disorder (ASD) poses a significant risk of permanent physical ...
Clinical Trials Arena on MSN20h
Neurocrine Biosciences debuts new data for effectiveness of IngrezzaOf the 103 patients who completed the Phase III trial, more than half witnessed remission from a drug-induced condition that ...
In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on earnings, a collaboration LOI ...
Speaking on BBC One's Sunday With Laura Kuenssberg, Wes Streeting, the UK health secretary, expressed concerns that some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback